Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
20 hours ago · Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Dr. Reddy's Laboratories, including: Last traded price 6888.95, Market capitalization: 114331.73, Volume: 341, Price-to-earnings ratio 20.5, Earnings per share 334.35.
3 days ago · 25 Jul 2024, 12:35 PM IST. Nestle India Ltd. and Dr Reddy's Laboratories Ltd. have announced the formation of a joint venture, which will be called Dr. Reddy’s and Nestlé Health Science Ltd. Nestle will hold 49% equity in Dr. Reddy’s Nutraceuticals Ltd., an erstwhile subsidiary of Dr. Reddy's Laboratories, with the rest owned by the latter ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
Jul 18, 2024 · Hyderabad-based Dr. Reddy’s Laboratories has announced the signing of a non-exclusive patent licensing agreement with Japanese drug maker Takeda Pharmaceutical Company. This collaboration aims to introduce Vonoprazan tablets, a novel treatment for gastrointestinal disorders, to patients across India.
